Patent foramen ovale: The evident paradox between the apparently simple treatment and the really complex pathophysiology

Journal of Cardiovascular Medicine

Volumn 8, Issue 4, 2007, Pages 300-304

  Rigatelli, Gianluca ^a,b  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Catheterization; Congenital heart disease; Patent foramen ovale; Stroke

Indexed keywords

NICKEL;

ANEURYSM; BLOOD CLOTTING DISORDER; BRAIN EMBOLISM; CARDIOLOGIST; CARDIOVASCULAR EQUIPMENT; CLINICAL EFFECTIVENESS; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART MUSCLE ISCHEMIA; HEART RIGHT LEFT SHUNT; HUMAN; INTERMETHOD COMPARISON; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; REVIEW; SKILL; THROMBOGENESIS; VEIN THROMBOSIS;

EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PATIENT CARE TEAM; TREATMENT OUTCOME;

EID: 34247127725     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000263497.99157.77     Document Type: Review

References (45)

1. Meier B. PFO closure, when the going gets tough. Catheter Cardiovasc Interv 2005; 64:345-347.
2. Windecker S, Meier B. Interventional PFO closure: what we see is but the tip of the iceberg. Catheter Cardiovasc Interv 2000; 50:199-201.
3. Dogu E, Stohr A, Zick-Bogemann R, Hegeler-Molkewehrum C, Hartmann H, Engel HJ. Platypnea-orthodeoxia of a 69-year-old woman with a patent foramen ovale. Z Kardiol 2004; 93:403-406.
4. Cartoni D, De Castro S, Valente G, Costanzo C, Pelliccia A, Beni S, et al. Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. Am J Cardiol 2004; 94:270-273.
5. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52:1622-1625.
6. Rigatelli G. Normal angiogram in patients with acute coronary syndrome: searching for unusual substrates of myocardial ischemia. Int J Cardiol 2005; 99:25-27.
7. Rigatelli GL, Rigatelli G, Rossi P, Docali G. Normal angiogram in acute coronary syndromes: the underestimated role of alternative substrates of myocardial ischemia. Int J Cardiovasc Imag 2004; 20:471-475.
8. Hacievliyagil SS, Gunen H, Kosar FM, Sahin I, Kilic T. Prevalence and clinical significance of a patent foramen ovale in patients with chronic obstructive pulmonary disease. Respir Med 2005; 100:903-910.
9. Zanchetta M, Onorato E, Rigatelli G, Pedon L, Zennaro M, Maiolino P. Can posterior fossa lesions be a place for preventive patent foramen ovale transcatheter closure? J Invasive Cardiol 2004; 16:346-350.
10. Varma C, Benson LN, Warr MR, Yeo E, Yip J, Jaigobin CS, et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheter Cardiovasc Interv 2004; 62:519-525.
11. Daehnert I, Ewert P, Berger F, Lange PE. Echocardiographically guided closure of a patent foramen ovale during pregnancy after recurrent strokes. J Interv Cardiol 2001; 14:191-192.
12. Kong H, Wilkinson JL, Coe JY, Gu X, Urness M, Kim TH, Bass JL. Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young 2002; 12:260-265.
13. Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J 2003; 145:737-741.
14. Singh HR, Turner DR, Forbes TJ. Nickel allergy and the Amplatzer septal occluder. J Invasive Cardiol 2004; 16:681-682.
15. Vincent RN, Raviele AA, Diehl HJ. Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. J Interv Cardiol 2003; 16:79-82.
16. Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H, Seiler C, Meier B. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004; 90:186-190.
17. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, Sievert H. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J Am Coll Cardiol 2004; 43:302-309.
18. Rigatelli G, Braggion G, Chinaglia M, Giordan M, Cardatoli P, Zonzin P, Chinaglia M. Deep vein thrombosis before patent foramen ovale closure. Am J Med 2005; 119:97-98.
19. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44:750-758.
20. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004; 25:424-430.
21. Onorato E, Melzi G, Casilli F, Pedon L, Rigatelli G, Carrozza A, et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003; 16:43-50.
22. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting Eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004; 17:231-233.
23. Onorato E, Pera IG, Melzi G, Rigatelli G. Persistent redundant Eustachian valve interfering with Amplatzer PFO occluder placement: anatomicoclinical and technical implications. Catheter Cardiovasc Interv 2002; 55:521-524.
24. Muench A, Boccalandro F, Ellis K, Smalling RW. Approaches to correct device malposition in percutaneous PFO closure: anatomical and technical implications. Catheter Cardiovasc Interv 2005; 64:338-344.
25. Ischinger TA, Kemkes B, Boosfeld C. Partial malposition of PFO closure device: indication for elective surgical removal? Discussion of indications, procedural and anatomical aspects. Z Kardiol 2003; 92:188-192.
26. Zanchetta M, Rigatelli G, Pedon L, Zennaro M, Onorato E, Maiolino P. Intracardiac echocardiography during catheter-based procedures: ultrasound system, examination technique, and image presentation. Echocardiography 2002; 19:501-507.
27. Rigatelli G, Zanchetta M, Onorato E, Pedon L, Zennaro M, Visentin E, et al. A fenestrated fossa ovalis aneurysm mimicking an atrial septal defect: correct diagnosis and treatment by intracardiac echocardiography. Ital Heart J 2002; 3:538-539.
28. Pees C, Haas NA, von der Beek J, Ewert P, Berger F, Lange PE. Cardiac troponin I is increased after interventional closure of atrial septal defects. Catheter Cardiovasc Interv 2003; 58:124-129.
29. Casolo G, Gensini GF, Santoro G, Rega L. Anomalous origin of the circumflex artery and patent foramen ovale: a rare cause of myocardial ischaemia after percutaneous closure of the defect. Heart 2003; 89:E23.
30. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63:496-502.
31. Trepels T, Zeplin H, Sievert H, Billinger K, Krumsdorf U, Zadan E, Horvath K. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003; 58:111-113.
32. Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45:1213-1218.
33. Beitzke A, Schuchlenz H, Gamillscheg A, Stein JI, Wendelin G. Catheter closure of the persistent foramen ovale: mid-term results in 162 patients. J Interv Cardiol 2001; 14:223-229.
34. Khositseth A, Cabalka AK, Sweeney JP, Fortuin FD, Reeder GS, Connolly HM, Hagler DJ. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004; 79:35-41.
35. Ferrari J, Baumgartner H, Tentschert S, Dorda V, Lang W, Willfort-Ehringer A, et al. Cerebral microembolism during transcatheter closure of patent foramen ovale. J Neurol 2004; 251:825-829.
36. Zanchetta M, Rigatelli G, Ho SY. A mystery featuring right-to-left shunting despite normal intracardiac pressure. Chest 2005; 128:998-1002.
37. Kilner PJ, Yang GZ, Wilkes AJ, Mohiaddin RH, Firmin DN, Yacoub MH. Asymmetric redirection of flow through the heart. Nature 2000; 404:759-761.
38. Rodriguez CJ, Homma S. Hypercoagulable states in patients with patent foramen ovale. Curr Hematol Rep 2003; 2:435-441.
39. Chaturvedi S. Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci 1998; 160:158-160.
40. Dodge SM, Hassell K, Anderson CA, Keller J, Groves B, Carroll JD. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure. Catheter Cardiovasc Interv 2004; 61:123-127.
41. Schussler JM, Phillips SD, Anwar A. Pulmonary arteriovenous fistula discovered after percutaneous patent foramen ovale closure in a 27-year-old woman. J Invasive Cardiol 2003; 15:527-529.
42. Zanchetta M, Rigatelli G, Pedon L, Zennaro M, Maiolino P, Onorato E. Transcatheter Amplatzer duct occluder closure of direct right pulmonary to left atrium communication. Catheter Cardiovasc Interv 2003; 58:107-110.
43. Mugge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 91:2785-2792.
44. Serafini O, Misuraca G, Greco F, Bisignani G, Manes MT, Venneri N. Prevalence of structural abnormalities of the atrial septum and their association with recent ischemic stroke or transient ischemic attack: echocardiographic evaluation in 18631 patients. Ital Heart J Suppl 2003; 4:39-45.
45. Guntheroth WG, Schwaegler R, Trent E. Comparative roles of the atrial septal aneurysm versus patent foramen ovale in systemic embolization with inferences from neonatal studies. Am J Cardiol 2004; 94:1341-1343.